Literature DB >> 16142463

[Opioids for cancer pain treatment. Efficacy and side effects].

E Klaschik1, K E Clemens.   

Abstract

In Germany, about 400,000 people per year are diagnosed with cancer. In the terminal stage of their disease, up to 95% of cancer patients suffer from pain. In earlier stages, this is true for about 50% of patients. It is estimated that 220,000 people in Germany are in need of cancer pain therapy. If the pain therapy is going to be changed, this must be comprehensively discussed with the patient in advance, particularly when strong opioids are used which are mostly indicated in these patients. Opioids are effective and reliable drugs when pain therapy is performed according to the basic principles. It is widely agreed that the WHO analgesic ladder serves as orientation and that the choice of substances must be suited to the cause and pathophysiological type of pain. Even though a variety of other strong opioids is in clinical use, morphine remains the reference substance for efficacy and occurrence of side effects in opioids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142463     DOI: 10.1007/s00482-005-0425-8

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  21 in total

1.  Pharmacokinetics of nortilidine and naloxone after administration of tilidine/naloxone solution or tilidine/naloxone sustained release tablets.

Authors:  U Brennscheidt; K U Seiler; P Thomann
Journal:  Arzneimittelforschung       Date:  2000-11

2.  Switching to methadone.

Authors:  R E Enck
Journal:  Am J Hosp Palliat Care       Date:  2001 May-Jun       Impact factor: 2.500

3.  Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.

Authors:  J Santiago-Palma; N Khojainova; C Kornick; D J Fischberg; L H Primavera; R Payne; P Manfredi
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

4.  Addiction rare in patients treated with narcotics.

Authors:  J Porter; H Jick
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

5.  Buprenorphine TDS: use in daily practice, benefits for patients.

Authors:  Lukas Radbruch
Journal:  Int J Clin Pract Suppl       Date:  2003-02

6.  [Prescription of strong opioids by general practitioners in Germany.].

Authors:  G Lindena; T Zenz
Journal:  Schmerz       Date:  1994-12       Impact factor: 1.107

7.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Authors:  R B Raffa; E Friderichs; W Reimann; R P Shank; E E Codd; J L Vaught
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

8.  Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

Authors:  C Ripamonti; L Groff; C Brunelli; D Polastri; A Stavrakis; F De Conno
Journal:  J Clin Oncol       Date:  1998-10       Impact factor: 44.544

9.  [What do we know about the prevalence of pain caused by malignancy?].

Authors:  E Heidemann
Journal:  Schmerz       Date:  1999-08-19       Impact factor: 1.107

10.  Unexpected complication of successful nerve block. Morphine induced respiratory depression precipitated by removal of severe pain.

Authors:  G W Hanks; R G Twycross; J W Lloyd
Journal:  Anaesthesia       Date:  1981-01       Impact factor: 6.955

View more
  4 in total

1.  [Side effects of pain therapy : Sufficient analgesia without unnecessary complications].

Authors:  F Greul; A Zimmer; W Meißner
Journal:  Urologe A       Date:  2017-04       Impact factor: 0.639

2.  [Chronic pain therapy for patients with head and neck tumors].

Authors:  A Walz; B Haberland; B Wollenberg; C Bausewein
Journal:  HNO       Date:  2006-10       Impact factor: 1.284

3.  Effects of acupuncture for cancer pain and quality of life - a case series.

Authors:  Sivarama Prasad Vinjamury; Ju-Tzu Li; Eric Hsiao; Calen Huang; Cheryl Hawk; Judith Miller; Yuhong Huang
Journal:  Chin Med       Date:  2013-07-30       Impact factor: 5.455

4.  A pilot study of acupuncture at pain acupoints for cervical cancer pain.

Authors:  Fan-Feng Meng; Yan-Hong Feng
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.